Lonza’s Vacaville Site: Delivering New CDMO Capacity at Scale

Discover how Lonza's acquisition and expansion of the Vacaville site delivers unprecedented mammalian cell culture capacity and robust manufacturing scale for global biopharma pipelines.

Read the full article for detailed industry insights →

LEAVE A REPLY

Please enter your comment!
Please enter your name here